Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 29-Feb-24 6:50 PM View:  | Ligand Pharmaceuticals Inc. (LGND) | 27-Feb-24 | Grant | 14,416 | -- | -- | 16% 89.44K to 103.86K | |
| 16-Feb-24 8:10 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-24 | Payment of Exercise | 4,778 | $74.65 | $356,678.00 | (5%) 94.22K to 89.44K | |
| 04-Jan-24 4:07 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 02-Jan-24 | Payment of Exercise | 2,917 | $72.31 | $210,928.00 | (3%) 97.14K to 94.22K | |
| 06-Dec-23 3:27 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 05-Dec-23 | Payment of Exercise | 1,984 | $59.61 | $118,266.00 | (2%) 99.12K to 97.14K | |
| 10-Jul-23 6:42 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Jun-23 | Acquisition (other) | 376 | $56.78 | $21,349.30 | < 1% 98.75K to 99.12K | |
| 27-Feb-23 8:52 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 23-Feb-23 | Grant | 9,069 | -- | -- | 10% 89.68K to 98.75K | |
| 17-Feb-23 7:23 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-23 | Payment of Exercise | 2,890 | $72.98 | $210,912.00 | (3%) 92.57K to 89.68K | |
| 30-Dec-22 5:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Dec-22 | Payment of Exercise | 3,859 | $66.29 | $255,813.00 | (4%) 96.43K to 92.57K | |
| 15-Dec-22 6:17 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 13-Dec-22 | Grant | 14,000 | -- | -- | 17% 82.43K to 96.43K | |
| 01-Dec-22 9:42 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Nov-22 | Payment of Exercise | 3,593 | $72.90 | $261,930.00 | (4%) 86.02K to 82.43K | |
| 03-Nov-22 9:10 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Nov-22 | Grant | 27,714 | -- | -- | 48% 58.31K to 86.02K | |
| 06-Jul-22 8:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Jun-22 | Acquisition (other) | 164 | $75.84 | $12,437.30 | < 1% 52.37K to 52.53K | |
| 14-Jun-22 5:54 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jun-22 | Grant | 8,062 | -- | -- | 18% 44.31K to 52.37K | |
| 16-Feb-22 8:23 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-22 | Payment of Exercise | 3,407 | $123.68 | $421,378.00 | (7%) 47.71K to 44.31K | |
| 28-Jan-22 8:43 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 26-Jan-22 | Grant | 11,651 | -- | -- | 29% 39.69K to 51.34K | |
| 28-Jan-22 8:43 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 26-Jan-22 | Payment of Exercise | 3,628 | $113.68 | $412,431.00 | (7%) 51.34K to 47.71K | |
| 18-Feb-21 6:27 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-21 | Payment of Exercise | 2,309 | $172.46 | $398,210.00 | (6%) 41.75K to 39.44K | 25% |
| 05-Feb-21 5:02 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 03-Feb-21 | Grant | 10,819 | -- | -- | 35% 30.93K to 41.75K | |
| 27-Jan-21 7:03 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 25-Jan-21 | Grant | 7,108 | -- | -- | 27% 25.94K to 33.04K | |
| 27-Jan-21 7:03 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 25-Jan-21 | Payment of Exercise | 2,111 | $156.01 | $329,337.00 | (6%) 33.04K to 30.93K | 17% |
| 01-Jul-20 8:05 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Jun-20 | Acquisition (other) | 238 | $89.03 | $21,188.90 | < 1% 25.7K to 25.94K | |
| 18-Feb-20 5:05 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 13-Feb-20 | Grant | 6,848 | -- | -- | 34% 20.02K to 26.86K | |
| 26-Dec-19 2:01 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 20-Dec-19 | Grant | 4,979 | -- | -- | 29% 17.15K to 22.13K | |
| 26-Dec-19 2:01 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 20-Dec-19 | Payment of Exercise | 2,114 | $105.87 | $223,809.00 | (10%) 22.13K to 20.02K | (23%) |
| 03-Sep-19 7:34 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 03-Sep-19 | Market Purchase | 500 | $86.18 | $43,090.80 | 3% 16.65K to 17.15K | 51% |
| 02-Jul-19 9:49 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Jun-19 | Acquisition (other) | 182 | $97.03 | $17,659.00 | 1% 16.47K to 16.65K | |
| 24-Apr-20 7:24 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-19 | Payment of Exercise | 1,166 | $120.86 | $140,923.00 | (7%) 16.47K to 15.3K | (8%) |
| 13-Feb-19 4:35 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 11-Feb-19 | Grant | 6,404 | -- | -- | 64% 10.06K to 16.47K | |
| 25-Jan-19 4:30 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 23-Jan-19 | Grant | 4,648 | -- | -- | 69% 6.74K to 11.39K | |
| 25-Jan-19 4:30 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 23-Jan-19 | Payment of Exercise | 1,325 | $111.78 | $148,108.00 | (12%) 11.39K to 10.06K | (16%) |
| 29-Aug-18 8:35 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 29-Aug-18 | Option Exercise | 11,540 | $85.79 | $990,017.00 | 85% 13.56K to 25.1K | |
| 29-Aug-18 8:35 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 29-Aug-18 | Market Option Sale | 11,540 | $256.69 | $2,962,200.00 | (46%) 25.1K to 13.56K | 49% |
| 29-Aug-18 8:35 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 29-Aug-18 | Market Sale | 6,817 | $256.69 | $1,749,860.00 | (50%) 13.56K to 6.74K | 49% |
| 07-Aug-18 4:35 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 06-Aug-18 | Payment of Exercise | 836 | $226.74 | $189,555.00 | (6%) 14.39K to 13.56K | 43% |
| 03-Jul-18 3:27 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 29-Jun-18 | Acquisition (other) | 180 | $117.84 | $21,210.40 | 1% 14.21K to 14.39K | |
| 06-Mar-18 6:36 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 06-Mar-18 | Grant | 2,004 | -- | -- | 16% 12.76K to 14.77K | |
| 06-Mar-18 6:36 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 06-Mar-18 | Payment of Exercise | 550 | $165.87 | $91,228.50 | (4%) 14.77K to 14.21K | 22% |
| 06-Mar-18 6:36 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 02-Mar-18 | Grant | 3,074 | -- | -- | 32% 9.69K to 12.76K | |
| 16-Feb-18 5:37 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-18 | Payment of Exercise | 680 | $157.18 | $106,882.00 | (7%) 10.37K to 9.69K | 17% |
| 29-Dec-17 9:17 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Dec-17 | Grant | 3,750 | -- | -- | 46% 8.15K to 11.9K | |
| 29-Dec-17 9:17 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Dec-17 | Payment of Exercise | 1,530 | $138.66 | $212,150.00 | (13%) 11.9K to 10.37K | 6% |
| 17-Nov-17 5:11 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 17-Nov-17 | Market Sale | 6,559 | $142.63 | $935,510.00 | (45%) 14.71K to 8.15K | 9% |
| 08-Aug-17 5:50 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 06-Aug-17 | Payment of Exercise | 609 | $122.06 | $74,334.50 | (4%) 15.31K to 14.71K | (7%) |
| 05-Jul-17 6:44 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Jun-17 | Acquisition (other) | 243 | $87.12 | $21,171.40 | 2% 15.07K to 15.31K | |
| 28-Feb-17 10:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 24-Feb-17 | Grant | 7,017 | -- | -- | 77% 9.11K to 16.12K | |
| 28-Feb-17 10:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 24-Feb-17 | Payment of Exercise | 1,051 | $100.38 | $105,499.00 | (7%) 16.12K to 15.07K | (30%) |
| 28-Feb-17 10:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-17 | Payment of Exercise | 391 | $104.28 | $40,773.50 | (4%) 9.5K to 9.11K | (25%) |
| 03-Jan-17 4:38 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Dec-16 | Acquisition (other) | 40 | $86.37 | $3,454.74 | < 1% 10.07K to 10.11K | |
| 28-Feb-17 10:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 06-Aug-16 | Payment of Exercise | 609 | $123.30 | $75,089.70 | (6%) 10.07K to 9.46K | (6%) |
| 05-Jul-16 7:58 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Jun-16 | Acquisition (other) | 196 | $87.10 | $17,071.50 | 2% 9.87K to 10.07K |